| Dr Yashvir Sangwan, MD | |
|
100 E Carroll St, Division Of Pulmonary And Critical Care, Salisbury, MD 21801-5422 | |
| (410) 546-6400 | |
| Not Available |
| Full Name | Dr Yashvir Sangwan |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 100 E Carroll St, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205097698 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | D71743 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Salisbury, MD | Home health agency |
| Peninsula Regional Medical Center | Salisbury, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidalhealth Specialty Care Llc | 7113340845 | 182 |
News Archive
Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.
One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of Advanced Therapy for Metabolic Disease, Kobe University Graduate School of Medicine) has clarified the mechanism underlying the development of diabetes and non-alcoholic steatohepatitis (NASH), a severe form of fatty liver.
› Verified 7 days ago
| Entity Name | Tidalhealth Peninsula Regional, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184832040 PECOS PAC ID: 3072509702 Enrollment ID: O20040420001571 |
News Archive
Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.
One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of Advanced Therapy for Metabolic Disease, Kobe University Graduate School of Medicine) has clarified the mechanism underlying the development of diabetes and non-alcoholic steatohepatitis (NASH), a severe form of fatty liver.
› Verified 7 days ago
| Entity Name | Shock Trauma Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679512909 PECOS PAC ID: 6800882317 Enrollment ID: O20040421000976 |
News Archive
Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.
One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of Advanced Therapy for Metabolic Disease, Kobe University Graduate School of Medicine) has clarified the mechanism underlying the development of diabetes and non-alcoholic steatohepatitis (NASH), a severe form of fatty liver.
› Verified 7 days ago
| Entity Name | Tidalhealth Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619504735 PECOS PAC ID: 7113340845 Enrollment ID: O20200714000286 |
News Archive
Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.
One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of Advanced Therapy for Metabolic Disease, Kobe University Graduate School of Medicine) has clarified the mechanism underlying the development of diabetes and non-alcoholic steatohepatitis (NASH), a severe form of fatty liver.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yashvir Sangwan, MD 309 Mill Pond Ln, Apt 273, Salisbury, MD 21804-2144 Ph: (330) 261-5031 | Dr Yashvir Sangwan, MD 100 E Carroll St, Division Of Pulmonary And Critical Care, Salisbury, MD 21801-5422 Ph: (410) 546-6400 |
News Archive
Columbia Laboratories, Inc. has entered into a definitive agreement to sell substantially all of its progesterone related assets and 11.2 million shares of common stock to Watson Pharmaceuticals, Inc. for a $47 million upfront payment plus royalties of 10 to 20 percent of annual net sales of certain progesterone products. Additional payments up to $45.5 million can be earned by the successful completion of clinical development milestones in the ongoing PREGNANT Study, regulatory filings, receipt of regulatory approvals and product launches.
One in three women suffer from pelvic floor dysfunction, a range of symptoms which include bladder and bowel problems as well as pelvic pain, according to the American Urogynecologic Society. Now, University of Missouri researchers have demonstrated that a comprehensive, nonsurgical treatment significantly improves symptoms in women with PFD.
The California Pharmacists Association (CPhA) today announced its support for a lawsuit filed December 3, 2013 in San Francisco Superior Court against the California Department of Health Care Services (DHCS) over the Medi-Cal provider reimbursement cuts.
A research group including Professor OGAWA Wataru (Division of Diabetes and Endocrinology, Kobe University Graduate School of Medicine) and Project Associate Professor HOSOOKA Tetsuya (Division of Development of Advanced Therapy for Metabolic Disease, Kobe University Graduate School of Medicine) has clarified the mechanism underlying the development of diabetes and non-alcoholic steatohepatitis (NASH), a severe form of fatty liver.
› Verified 7 days ago
Leslie Michelle Belloso, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3911 Devonshire Dr, Salisbury, MD 21804 Phone: 410-548-4514 | |
Charles B Silvia Jr., MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 100 E Carroll St, Inpatient Services, Salisbury, MD 21801 Phone: 410-543-7536 Fax: 410-543-7272 | |
Dr. Curtis Harris Jr., M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 224 Phillip Morris Dr, Salisbury, MD 21804 Phone: 410-831-3174 Fax: 410-630-5379 | |
Jack L Snitzer, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1415 S Division St, Suite A, Salisbury, MD 21804 Phone: 410-572-8848 | |
Sharad R Satyal, M. D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 910 Eastern Shore Dr, Salisbury, MD 21804 Phone: 410-546-1331 Fax: 410-543-8107 | |
Dr. Hameem I Kawsar, MD., PH.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 | |
Dr. Michael B Hess, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 100 E Carroll St, Salisbury, MD 21801 Phone: 410-546-6400 Fax: 225-765-9196 |